![CLASH enables large-scale parallel knock-in for cell engineering](https://dailytalks.org/wp-content/uploads/2023/03/41880-clash-enables-large-scale-parallel-knock-in-for-cell-engineering.png)
Nature Biotechnology, Published online: 26 January 2023; doi:10.1038/s41587-023-01664-4CLASH is a CRISPR-based platform that enables the parallel knock-in via homology-directed repair of a large pool of transgene variants encoded in adeno-associated virus vectors. CLASH can be applied to the systematic and unbiased selection of favorable features in T cells and…
Read More